Mark Taylor
About Mark Taylor
Mark Taylor is the President and CEO of Curexa, a co-founder of the company, and a Registered Pharmacist in Charge since 2003. He holds degrees in pharmacy and business administration and has held various leadership roles in the New Jersey Pharmacy Association.
Mark Taylor - President and CEO of Curexa
Mark Taylor serves as the President and CEO of Curexa. Under his leadership, the company has focused on delivering innovative pharmaceutical solutions. As a co-founder, Taylor has been integral in shaping Curexa's business strategies and operations since its inception. His role encompasses overseeing all aspects of the company's activities, ensuring that Curexa meets its goals and maintains a high standard in the pharmaceutical industry.
Mark Taylor's Education and Qualifications
Mark Taylor holds a Bachelor of Science degree in pharmacy from the Philadelphia College of Pharmacy and Science. He furthered his education by earning a Master of Business Administration from Temple University. This combination of pharmaceutical and business education equips him with a unique perspective and a robust skill set, enabling him to effectively lead in the healthcare and pharmaceutical sectors.
Mark Taylor's Professional Background in Pharmacy
Since 2003, Mark Taylor has served as the Registered Pharmacist in Charge at Curexa. Additionally, he is a former president of the New Jersey Pharmacy Association (NJPhA). His extensive background in pharmacy practice includes his recent election to the treasurer position at NJPhA, effective January 2023. Taylor's experience and roles reflect his deep commitment to advancing the field of pharmacy.
Mark Taylor's Volunteer Work in Pharmacy
Mark Taylor actively volunteers his time to advance pharmacy practice. His volunteer efforts focus on improving the pharmaceutical field and ensuring that innovative solutions are developed and implemented. His dedication to the industry extends beyond his professional obligations, showcasing his commitment to making meaningful contributions to the pharmacy community.